Top Tweets for #MyeloMATCH
Precision medicine in AML is no longer a future concept—it’s becoming clinical reality.
The NCI-led #MyeloMATCH program is redefining AML/MDS care through rapid genomic profiling, molecularly assigned therapies, and MRD-guided interventions—bringing the right treatment to the right patient at the right time.
Join international experts as they share insights from the first two years of MyeloMATCH and explore how these lessons may shape leukemia care worldwide.
📅 23 June 2026
🕢 7:30 PM IST
https://t.co/kNi6ZquM8q
A must-attend event for hematologists, oncologists, pathologists, molecular scientists, and trainees.
#AML #MDS #Leukemia #PrecisionOncology #Genomics #Hematology
@RahulDoc2 @drshrinidhi2020 @royjpalatty @shanuaswam @DrNeha90356702 @Rajagiri_Hosptl
A new #myeloMATCH clinical trial, #CCTG ALC10 has opened in Canada! Exploring a new treatment option for older adults with acute myeloid leukemia #AML who may not be able to tolerate intensive chemotherapy.
https://t.co/MNWSd53BO7
#Hematology #ClinicalTrials
@BCCancer @SWOG
On the latest episode of the Bench to Bedside podcast, Dr. Tara Lin and Dr. Jesus Gonzalez Lugo share an update on #MyeloMATCH, a first-of-its-kind national clinical trial designed to bring precision medicine to patients with #AML. Tune in today: https://t.co/ggYGRAtQ1R
#myeloMATCH is a large @theNCI research study testing treatments for adults with #AML or #MDS. Patients join before starting treatment & may have #ClinicalTrial options at all treatment stages. @ALLIANCE_org @CDNCancerTrials @eaonc @SWOG 1-800-4-CANCER or https://t.co/nNq0b6frLs
The @theNCI #MyeloMATCH precision medicine trial for #AML or #MDS has some initial results that are being presented in an oral presentation and 5 posters at the #ASH25 meeting this weekend! Find out more here > https://t.co/3F00YotqjI
@SWOG
@eaonc
@ALLIANCE_org
#NCORP
Wrapped up a great (and 1st!) @eaonc Fall Meeting in Philly! 🌆 Great talks on innovative tx, trial design and 📈role of AI. Great mentorship for 🐣🕵️
🌟Exciting things ahead in #MyeloMATCH #leusm
🎉 to @keruakous of @GACancerCenter leading EAA241, an important Ph II MM trial!
Under-48-hour #RapidNGS is turning “wait a week” into “treat today.” ⚡️🧬
Same run → DNA RNA, on-the-spot FLT3/IDH calls, real-time #myeloMATCH trial slots, and a fighting chance for aggressive AML.Precision moves fast—so must we.happening at Fortis!!!! @RahulDoc2 @nikhil91sjmc
Thank you @LeukDocJZ and @TapKadia for moderating an outstanding session! I learned a lot and believe the future is 3 (++) in appropriate settings and we need to do some more work to improve accessibility and safety. 🧡 #MyeloMatch @Daver_Leukemia @doctorpemm
Fantastic debate about sequential therapies (Harry Erba) versus Triplets (@jaltmanmd) in AML. “The coolest things come in 3’s.” Triplets are already being developed in pivotal randomized trials. Fascinating discussion panel! @_MDEducation
Testing for certain features in cancer (biomarkers) can tell doctors about what’s causing it to grow. The #myeloMATCH study uses advanced biomarker testing for adults with #AML or #MDS.
1-800-4-CANCER or https://t.co/QH7JSTgEPw
@theNCI @ALLIANCE_org @CDNCancerTrials @eaonc @SWOG
#myeloMATCH is the NCI’s #PrecisionMedicine trial in #myeloid cancers. Substudy MM1OA-S03
enrolls patients who are age 60+ or unfit for chemo and have newly diagnosed AML with an
IDH2 gene mutation (~15% of pts).
https://t.co/h6uoanlmpH #leusm #leukemia
Don't forget the upcoming webinar exploring the National Cancer Institute (NCI) myeloMATCH program. Click here to register: https://t.co/OdBZamkVXN
#genomics #cancer #research #genetics #clinicaltesting #bioinformatics #cytogenetics #molecular #myeloMATCH
#CCTG has presented the Phase III Program Team Award for an intergroup led trial to the ALC.7 team from Arthur J.E. Child Comprehensive Cancer Centre for their performance on this #myeloMATCH protocol. #CCTG2025
#myeloMATCH is an @theNCI research study with biomarker testing for people just diagnosed with acute #myeloid #leukemia (#AML) or #myelodysplastic syndrome (#MDS). Ask your doctor to learn more.
@Alliance_org @CDNCancerTrials @eaonc @SWOG
1-800-4-CANCER or https://t.co/ktnWTVHtQH
Proud to be part of this study with my study cochair Dr. Eric Huselton from University of Rochester @OSUHematology @OSUCCC_James . #myeloMATCH #olderadults #AML @theNCI @NIH @FDAOncology
#myeloMATCH sub-study MM1OA-S03 is activated!
Patients registered to the MYELOMATCH screening protocol who are 60+ or unfit for chemo and have AML w an IDH2 gene mutation may be assigned to MM1OA-S03. Pts randomized to venetoclax + ASTX727 w/wo enasidenib.
https://t.co/h6uoankOA9
#myeloMATCH sub-study MM1OA-S03 is activated!
Patients registered to the MYELOMATCH screening protocol who are 60+ or unfit for chemo and have AML w an IDH2 gene mutation may be assigned to MM1OA-S03. Pts randomized to venetoclax + ASTX727 w/wo enasidenib.
https://t.co/h6uoankOA9
#myeloMATCH substudies treat patients with #AML or #MDS sequentially from diagnosis thru all treatment stages. After each treatment, patients are rescreened for assignment to a substudy in another tier.
@theNCI @Alliance_org @CDNCancerTrials @eaonc @SWOG
https://t.co/um1byHWRdQ
#myeloMATCH is a research study for adults with #AML or #MDS who have not begun treatment. It uses advanced testing to look for cancer biomarkers that can be targeted by new treatments.
@theNCI @ALLIANCE_org @CDNCancerTrials @eaonc @SWOG
1-800-4-CANCER or https://t.co/ffPe6RBT0P
The #CCTG ALC8 trial has opened, testing the effects of novel therapeutics for newly diagnosed, untreated acute myeloid leukemia #AML patients. This trial is part of the #myeloMATCH precision medicine protocol for #AML #MDS patients. #SolvingCancerTogether
https://t.co/Hdr8PqpQog
#myeloMATCH MM1YA-S01 is enrolling adults ages 18-59 with newly diagnosed high-risk #AML.
Randomized 5-arm comparison of induction therapies. Primary endpoint: MRD-negative complete remission rate. https://t.co/tHEbp3R5K6
Co-PI: Tara Lin, MD @KUcancercenter #leusm #AMLsm
MM1YA-S01 is a treatment study for adults aged 18-59 with high-risk #AML (acute myeloid #leukemia). It’s part of the #myeloMATCH #clinicaltrial. Learn more at https://t.co/0a3wEoMudO. Or call 1-800-4-CANCER. Ask about MM1YA-S01. #leusm #AMLsm @LLSusa
Last Seen Hashtags on Sotwe
desahancewek
Seen from Indonesia
trans outdoor
Seen from Indonesia
russianp
Seen from Poland
ibumenyusui
Seen from Indonesia
EtBonDimanche
Seen from Brazil
dumbification
Seen from United Kingdom
gaykiffeur
Seen from France
rooom
Seen from Japan
chubby
Seen from United States
shoetrampling
Seen from Turkey
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.7M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.8M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
90.9M followers
KATY PERRY
@katyperry
87.8M followers
Taylor Swift
@taylorswift13
81.6M followers
Lady Gaga
@ladygaga
73.1M followers
Virat Kohli
@imvkohli
70M followers
Kim Kardashian
@kimkardashian
69.8M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.9M followers
Neymar Jr
@neymarjr
62.8M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
60.8M followers
X
@x
60.8M followers